PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 28 filers reported holding PROTEON THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $0 | -100.0% | 132 | -98.7% | 0.00% | – |
| Q1 2019 | $5,000 | -94.9% | 10,037 | -76.8% | 0.00% | – |
| Q4 2018 | $98,000 | +9700.0% | 43,188 | +9391.9% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 455 | +13.2% | 0.00% | – |
| Q1 2018 | $1,000 | – | 402 | +20000.0% | 0.00% | – |
| Q3 2017 | $0 | – | 2 | -99.4% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 317 | -88.1% | 0.00% | – |
| Q3 2016 | $24,000 | -4.0% | 2,659 | -14.9% | 0.00% | – |
| Q2 2016 | $25,000 | +13.6% | 3,124 | +7.7% | 0.00% | – |
| Q1 2016 | $22,000 | -79.2% | 2,900 | -57.4% | 0.00% | – |
| Q4 2015 | $106,000 | +146.5% | 6,807 | +122.0% | 0.00% | – |
| Q3 2015 | $43,000 | -65.3% | 3,066 | -56.0% | 0.00% | – |
| Q2 2015 | $124,000 | +4033.3% | 6,968 | +2222.7% | 0.00% | – |
| Q1 2015 | $3,000 | -40.0% | 300 | -43.2% | 0.00% | – |
| Q4 2014 | $5,000 | – | 528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 315,101 | $599,000 | 25.51% |
| Abingworth LLP | 2,017,872 | $3,632,000 | 3.04% |
| Pharmstandard International S.A. | 1,165,344 | $2,214,000 | 1.91% |
| MPM ASSET MANAGEMENT LLC | 983,381 | $1,868,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,332,599 | $2,532,000 | 0.10% |
| Perceptive Advisors | 334,116 | $635,000 | 0.04% |
| Baker Brothers Advisors | 389,394 | $740,000 | 0.01% |
| WEDBUSH SECURITIES INC | 17,000 | $32,000 | 0.01% |
| FINANCIAL COUNSELORS INC | 50,000 | $95,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 11,499 | $21,000 | 0.00% |